Vol. 6, 2026April 21, 2026 BST
ccby-4.0
Spinal presentations in children with Spinal Muscular Atrophy type 1 following Gene Therapy treatment with onasemnogene abeparvovec – the SMA-REACH UK network experience.
Spinal presentations in children with Spinal Muscular Atrophy type 1 following Gene Therapy treatment with onasemnogene abeparvovec – the SMA-REACH UK network experience.
Jonathan Lucas, Jennie Sheehan, Alex Schofield, Helen Cranney, Amy Wolfe, Emer O'Reilly, Georgia Stimpson, Alice Andrews, Maria Venegas, Mark Harris, Mariacristina Scoto, Vasantha Gowda, Elizabeth Wraige, Heinz Jungbluth,
Lucas, Jonathan, Jennie Sheehan, Alex Schofield, Helen Cranney, Amy Wolfe, Emer O’Reilly, Georgia Stimpson, et al. 2026. “Spinal Presentations in Children with Spinal Muscular Atrophy Type 1 Following Gene Therapy Treatment with Onasemnogene Abeparvovec – the SMA-REACH UK Network Experience.” Column & Cord 6 (April).